Gaete Margarita Enberg, Valenzuela Marcela Puente, Bachero Aniela Wozniak, Vega Claudia Castillo, Marín Nicolás Villagra, Labarca Jaime Labarca, Cañete Patricia García
Departamento de Enfermedades Infecciosas del Adulto, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Departamento de Laboratorios Clínicos, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Rev Chilena Infectol. 2020 Aug;37(4):389-394. doi: 10.4067/S0716-10182020000400389.
Pseudomonas aeruginosa is a relevant infectious agent affecting patients within health care setting; this situation is worsening with the appearance of strains resistance to carbapenems.
To study carbapenemase production in P. aeruginosa with decreased susceptibility to carbapenems processed in the microbiology laboratory of the Health Network UC-CHRISTUS in 2014-2015 and compare them with the strains studied in 2004-2005.
Between January 2014 and June 2015, 459 strains of P. aeruginosa from clinical samples were isolated. Susceptibility was determined by dilution in agar and strains with reduced susceptibility to carbapenems were tested for carbaNP. Positive strains were studied by PCR for blaVIM, blaVIM-1, blaVIM-2, blaIMP, blaNDM, blaKPC, blaOXA and blaIMI genes. Pulsed field electrophoresis was performed on selected strains.
From 459 strains studied, 300 had reduced susceptibility to carbapenems (65.3%). Of these, 183 were viable for study, corresponding to 164 patients. The carbaNP test was positive in 44 strains of the 183 strains (24%). The resistance genes found were: blaVIM-2 in 35 strains, blaKPC-2+VIM-2 in 7 strains and blaKPC-2 in 2 strains. In the blaKPC-2 strains clonal relation between them was found.
A 65.3% of P. aeruginosa presented decreased susceptibility to carbapenems being the presence of carbapenemases not the main resistance mechanism. In addition, the emergence in Chile of P. aeruginosa strains with bla of the KPC-2 type alone or in combination with VIM-2 is described.
铜绿假单胞菌是一种在医疗环境中影响患者的重要感染病原体;随着对碳青霉烯类耐药菌株的出现,这种情况正在恶化。
研究2014 - 2015年在UC - CHRISTUS健康网络微生物实验室处理的对碳青霉烯类敏感性降低的铜绿假单胞菌中碳青霉烯酶的产生情况,并将其与2004 - 2005年研究的菌株进行比较。
2014年1月至2015年6月,从临床样本中分离出459株铜绿假单胞菌。通过琼脂稀释法测定敏感性,对碳青霉烯类敏感性降低的菌株进行碳青霉烯酶检测(carbaNP)。对阳性菌株进行blaVIM、blaVIM - 1、blaVIM - 2、blaIMP、blaNDM、blaKPC、blaOXA和blaIMI基因的PCR研究。对选定菌株进行脉冲场凝胶电泳。
在研究的459株菌株中,300株对碳青霉烯类敏感性降低(65.3%)。其中,183株可用于研究,对应164例患者。在183株菌株中的44株(24%)碳青霉烯酶检测(carbaNP)呈阳性。发现的耐药基因有:35株中有blaVIM - 2,7株中有blaKPC - 2 + VIM - 2,2株中有blaKPC - 2。在blaKPC - 2菌株中发现了它们之间的克隆关系。
65.3%的铜绿假单胞菌对碳青霉烯类敏感性降低,碳青霉烯酶的存在不是主要耐药机制。此外,还描述了智利单独或与VIM - 2组合携带blaKPC - 2型的铜绿假单胞菌菌株的出现情况。